In the present work, several novel antigen peptides bearing these three PTMs relevant for RA but considering other proteins that are present in the rheumatoid synovial tissue, such as alpha-enolase or vimentin, have been designed and synthesized trying to address the still unmet need of identifying those RA patients who will develop ILD. Here, ENO1 is linked to rheumatoid arthritis.